17/10/2025
Global DNA Diagnostics Introducing NIFTY a cutting-edge Non-Invasive Fetal Trisomy Screening test which examines a sample of the mother’s blood to check for genetic conditions like trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 in the developing baby.
Key Benefits:
- Accurate Results: Over 99% sensitivity and specificity for trisomy 21, 18, and 13.
- Safe & Non-Invasive: A simple blood test from the mother, eliminating risks associated with invasive procedures.
- Early Detection: Can be performed as early as 10 weeks into pregnancy.
- Comprehensive Reporting: Clear, detailed results to help guide healthcare decisions.
- Global Trust: Used by healthcare providers around the world, ensuring reliability and expertise.
Contact our team on:
📲+263775740038
📲+263775740040
☎️+263242254411
info@globaldnaint.com
www.globaldnaint.com